Ernest Pharmaceuticals

Ernest Pharmaceuticals Overview

  • Founded
  • 2016
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Ernest Pharmaceuticals General Information


Developer of programmed bacteria designed to destroy cancer. The company's programmed bacteria designed is prepared using synthetic techniques and are motile and actively penetrates tumor tissue, enabling treatment of metastatic disease and inoperable tumors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Primary Office
  • 2 Ladyslipper Lane
  • Hadley, MA 01035
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ernest Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 23-Jan-2017 Completed Startup

Ernest Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Neil Forbes Founder & Manager

Ernest Pharmaceuticals Investors (1)

To view Ernest Pharmaceuticals‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Valley Venture Mentors Accelerator/Incubator 000 0000 000000 0

Ready to get started?

Request a free trial